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Key Clinical Message
To our knowledge, this is the first case report of juvenile dermatomyositis
(JDM) in Tanzania. It demonstrates that the characteristic cutaneous findings
of JDM may easily be overlooked, especially on dark skin, and the difficulty of
clinical management in resource-constrained settings.
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Introduction
Juvenile dermatomyositis (JDM) is a rare systemic
autoimmune disease in children affecting primarily the
sun-exposed skin, resulting in a distinctive cutaneous
eruption, and the proximal musculature. The age of onset
is between 2 and 13 years with 20% of patients presenting
before the age of 4 years. As opposed to adult dermato-
myositis, children present more often with small vessel
vasculopathy and inflammation plus necrosis of the mus-
cles. In addition, myositis-specific antibodies are less fre-
quently present, malignancies are sporadic, the mortality
rate is lower, and cutaneous calcifications are common
(up to 40%) [1]. To date, only few cases of JDM have
been reported in sub-Saharan Africa [2–5] of which none
from East Africa. We describe a 4-year-old Kenyan girl
who presented with calcinosis cutis most likely secondary
to JDM causing contractures.
Case Presentation
A 4-year-old, HIV-negative, Kenyan girl was admitted to
the Paediatric Ward of the Kilimanjaro Christian Medical
Centre (KCMC) in Moshi, Tanzania, with an 8-month
history of hard and painful, non-itchy nodules of the skin
of which some had ulcerated. The nodules had started
around her knees and elbows and had spread to the
shoulders. She had a dry cough since 2 weeks, general
malaise, a low-grade fever, weight loss since a few months
and was unable to walk. There was no history of night
sweats or exposure to tuberculosis. Otherwise, she had a
normal development and was the sixth child in a healthy,
nonconsanguineous family. She had already attended sev-
eral hospitals in her region, but no cause for the com-
plaints was found.
At physical examination, we saw an afebrile, ill-looking
and wasted child (length 1.03 m, weight 10 kg, BMI
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9.4 kg/m2). On the shoulders, elbows, and knees and
along the fascia of several proximal muscles, including
hamstrings, quadriceps, abdominal, and trapezius mus-
cles, multiple hard and calcified papules and nodules were
observed varying in size from 5 to 15 mm. Some of these
lesions expelled calcified material leaving ecthyma-like
ulcers (Figure 1B, D). Musculoskeletal inspection showed
mild contractures in knees, elbows and shoulder joints.
Upon neurological examination, the muscle bulk was in
proportion with her poor nutritional status, but not remi-
niscent of atrophy, as various limb girdle muscles
appeared still fairly normal and strong when tested
supine. However, she was not able to get up from the
supine position, elevate both her arms, or comb her hair
in the seated position. Gower’s sign was negative. Bedside
testing did not reveal outspoken muscle weakness, Medi-
cal Research Council scale was 4/5. However, pain may
have interfered with maximal contraction. There was no
distal weakness or atrophy. Reflexes and sensation were
unremarkable.
The dermatologist was consulted, and it was noticed
that the child had slight edema with hyperpigmentation
above the upper eyelids (heliotrope rash), small flat-
topped skin-colored papules over the proximal and distal
interphalangeal joints (possible early establishment of
Gottron’s papules), a hyperpigmented rash in her neck,
and a nonscarring alopecia (Figure 1A–C, E). There were
no further abnormalities of the skin, nails, or oral cavity.
Laboratory examinations revealed increased serum
levels of lactate dehydrogenase (LDH, 671 [reference value
240–480] U/l), alanine transaminase (ALT, 39 [2–33] U/
l), and aspartate aminotransferase (AST, 60 [2–31] U/l).
Serum creatine kinase (CK) was within the normal range
(158 [26–192] U/l). Full blood count, kidney function,
and serum phosphate and calcium levels were normal.
Erythrocyte sedimentation rate (ESR) was raised (70 [3–
13] mm/h). X-rays of chest, hips, and legs showed
numerous calcifications peri-articular and in the soft tis-
sues (Figure 2). Chest X-ray demonstrated parenchyma-
tous infiltrates compatible with pneumonia (likely due to
(A)
(D) (E)
(B) (C)
Figure 1. Edema with hyperpigmentation above the upper eyelids (heliotrope rash, A); ecthyma-like ulcer on the left shoulder and nonscarring
alopecia on the scalp (B); hyperpigmented rash in the neck (C); calcified papules and nodules around the knee of which some have expelled
calcified material (D); small flat-topped papules over the proximal and distal interphalangeal joints (possible early establishment of Gottron’s
papules, (E)
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aspiration in this bedridden child), but no evidence of
pulmonary tuberculosis. Skin biopsy from a nodule on
the knee revealed deposits of calcium in the dermis con-
firming the diagnosis of calcinosis cutis. No other
histopathological abnormalities were seen. We were not
able to perform (myositis-specific) autoantibodies, for
example, ANA and anti-Mi2, a muscle biopsy, elec-
tromyography, or MRI as these examinations at the time
were not available at KCMC. Based on the clinical, labo-
ratory, and histopathological findings, the diagnosis of
JDM was made.
The patient was started on oral prednisolone and
broadspectrum antibiotics (ceftriaxone and metronida-
zole), and physiotherapy was initiated. She showed mild
clinical improvement, but then disappeared from the hos-
pital ward a few days after initiation of treatment.
Discussion
JDM is a systemic autoimmune vasculopathy character-
ized by muscle weakness and distinctive skin findings.
The diagnostic criteria for JDM, as proposed by Bohan
and Peter, are included in Table 1 [6]. JDM is diagnosed
if four of these criteria are present, including the skin
rash; the diagnosis is probable in the presence of two cri-
teria in addition to the skin rash. Due to limited
resources, we did not perform a muscle biopsy, elec-
tromyography, or MRI to support our clinical impression.
The proximal muscle weakness could not be reliably
assessed due to concomitant pain and contractures, which
limited range of movement. This means that although
muscle weakness could not be directly demonstrated, it
may very well have been present. Hence, it should be
noted that the presented case does not fully comply with
the diagnostic criteria for JDM. Yet, to diagnose JDM in
daily practice on the basis of these criteria is challenging,
especially in resource-limited settings but also in young
children, as both electromyography and muscle biopsy are
invasive. Recently, an international survey among pedi-
atric rheumatologists demonstrated that proximal muscle
weakness, specific skin features, and raised muscle
enzymes were the most frequently used criteria for identi-
fying JDM. EMG and muscle biopsy were used as diag-
nostic support in only 56 and 61% of patients,
respectively [7]. Nowadays, MRI is increasingly replacing
the latter investigations, but is not always available in
low- and middle-income countries. In our patient, the
combination of probable proximal muscle weakness, the
rise of some of the muscle enzymes (LDH, ALT, AST)
and an elevated ESR, extensive calcinosis cutis and mini-
mal, but distinctive cutaneous lesions (heliotrope rash,
possible Gottron’s papules, skin ulcerations, and alopecia)
make the diagnosis of JDM very likely.
Dystrophic calcification is a well-recognized complica-
tion of JDM and involves the deposition of insoluble cal-
cium salts in the cutaneous and subcutaneous tissues.
Patients may present with firm to rock-hard irregular
nodules or with larger subcutaneous plaques along the
fascia or in the intramuscular connective tissue causing
extensive areas of calcification, leading to functional
impairment. Elbows, knees, buttocks, and shoulders are
typically affected. The calcified lesions may ulcerate and
discharge a white, chalky material causing ecthyma-like
lesions. Calcinosis is thought to be a consequence of pro-
longed inflammation and generally develops 2–3 years
after disease onset [8]. Our patient presented with wide-
spread calcifications in the skin and muscles, which
reflects delay in treatment of an active myositis, which is
not unusual in a setting like East Africa and may be
explained by financial constraints, lack of access to
(A) (B) (C)
Figure 2. X-ray of chest (A), hips (B), and knees (C) demonstrating numerous calcifications in joints, muscles, and subcutaneous tissues.
136 ª 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Juvenile dermatomyositis in Kenyan girl M. L. Grijsen et al.
appropriate care, and poor health education. However, it
may also be explained by JDM-specific autoantibodies like
nuclear matrix protein 2 (NXP2) that is associated with
calcinosis and severe myositis [9]. A recent retrospective
study from South Africa showed that African children
with JDM had high levels of dystrophic calcification and
low levels of muscle enzymes, particularly CK, suggesting
low-grade chronic inflammation [2].
Muscle-derived enzymes, of which CK is most com-
monly used, are often elevated in JDM indicating muscle
damage. In some cases, however, CK may be normal,
especially in the early and chronic stage of the disease. In
one study, one-third of the affected children with active
disease had a normal serum CK [1,10]. The South African
study revealed that the muscle enzymes, specifically CK,
were significantly lower in children with calcinosis com-
pared to those without calcifications [2]. Another study
demonstrated that in untreated JDM after 4.7 months,
the different muscle enzymes tended to be normal [11].
These studies highlight the importance of not merely rely-
ing on CK, but to determine other myositis-associated
enzymes, including transaminases, LDH, and aldolase, as
well. Additionally, it shows that as time without therapy
increases, the muscle enzymes may normalize. In our case,
the CK was normal, but LDH and transaminases were
raised. Serum aldolase was not available.
In our differential diagnosis, we considered primary
tumoral calcinosis, which is a hereditary disease, has been
described in patients of African descent, and is more
common in (sub)tropical regions [12,13]. However, we
deemed this to be less likely as tumoral calcinosis gener-
ally occurs in peri-articular soft tissues around hip, shoul-
ders, buttocks, and elbow joints and not along the
muscles/facies as in our case. Additionally, our patient
did not have an imbalance in calcium and phosphate
homeostasis, which sometimes is the case in tumoral cal-
cinosis, and had a negative family history despite having
five siblings. Finally, tumoral calcinosis does not explain
the constitutional and cutaneous symptoms and signs,
and raised muscle enzymes. Alternatively, we considered
juvenile systemic sclerosis (JSSc) as this may present with
muscle weakness and calcinosis cutis as well, and could
explain the abnormal pulmonary findings as autoimmune
pulmonary involvement. The majority of children with
JSSc, however, present with symmetrical hardening/thick-
ening of the skin and/or Raynaud phenomenon, which
was not the case in our child. Also, interstitial lung dis-
ease has been reported as a complication of JDM [14].
Nevertheless, without specific autoantibody testing, it is
not possible to completely rule out JSSc.
To our knowledge, this is the first report of JDM in
East Africa. The present case demonstrates that the char-
acteristic cutaneous findings of JDM may easily be over-
looked, especially on the black skin. It shows the
difficulty of clinical management and the importance of a
multidisciplinary approach in complex patients, especially
in settings where diagnostic means are limited.
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